API | diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine

diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine Report issue

Vaccine Experimental

AACT

Active Ingredient History

NOW

A hexavalent vaccine, or 6-in-1 vaccine, is a combination vaccine with six individual vaccines conjugated into one, intended to protect people from multiple diseases. The term usually refers to the children's vaccine that protects against diphtheria, tetanus, pertussis, poliomyelitis, haemophilus B, and hepatitis B, which is used in more than 90 countries around the world including in Europe, Canada, Australia, and New Zealand. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action:
- Diphtheria toxin (Corynebacterium diphtheriae) ^UniProt
- Tetanus toxin (Clostridium tetani (strain Massachusetts / E88)) ^UniProt
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

dtpw-hbv/hib | dtwp-hepb-hib vaccine | eutravac | hexaxim

Organizations (8)

Research & Development (8)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (15)

Approved Indications (3)

Diphtheria-Tetanus-Pertussis Vaccine

Haemophilus Vaccines

Poliovirus Vaccines

Experimental Indications - Clinical Trial Phases 1-4 (12)

Diphtheria (Phase 3)

Haemophilus Infections (Phase 3)

Haemophilus influenzae (Phase 3)

Haemophilus influenzae type b (Phase 3)

Healthy Volunteers (Phase 3)

Hepatitis B (Phase 3)

HIV (Phase 3)

Poliomyelitis (Phase 3)

Safety (Phase 3)

Streptococcal Infections (Phase 3)

Tetanus (Phase 3)

Whooping Cough (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 22
# of Trial Organizations: 8

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue